Cancer treatment remains as an expensive process due to the cost of sophisticated infrastructure development as well as its maintenance with skilled personnel. At the same time, the success rate is not very inspiring since non-specific target oriented medication could cause other health complexities leading to death. Research for alternative therapies aimed at minimizing the side effects of treatments and increasing the survival rates of patients includes routine explorations for anticancer agents from numerous sources (e.g. microbes, plants and nanoparticles). Anticancer activities of several bacterial components especially from Bacillus spp. were reported in many scientific reports. For economic production of these agents, potential strains from this genus could be feasible and sustainable for their long and successful utilization in industries. The review is therefore, focused on describing the available anticancer and anti-proliferative agents reported worldwide from Bacillus spp.
tor genes or genomic stability associated genes initiates carcinogenesis (Devi, 1989) . Cells involved in the initiation stage are subject to subsequent changes in the promotion stage upon prolonged exposures to promoting stimuli (Devi, 1989) . Malignant conversion, the third stage, is the transformation of a preneoplastic cell into the neoplastic one i.e. cell that expresses the malignant phenotypes. is could be caused by further genetic changes through exposure of preneoplastic cells to DNA-damaging agents or the activation of proto-oncogenes and inactivation of tumor suppressor genes (Weston & Harris, 2003) . In this stage, mutations in the genes of Ras proteins, the biological switches, and p53, the guardian of the genome, could lead to unregulated cell growth (Isoldi, Visconti, Maria, & Castrucci, 2005) . Finally, the tumor progression occurs by the expression of the more aggressive malignant phenotypes being accelerated by selection pressures or repeated exposures to carcinogenic stimuli with time. e malignant phenotypes have the tendency for genomic instability and uncontrolled growth (Devi, 1989; Weston & Harris, 2003) . Late in tumor progression, the fully malignant cells due to the accumulation of di erent genetic alterations (Yokota, 2000) lose their adherence capacity, detach from the tumor mass and invade the neighboring tissues leading to metastasis.
Metastasis, a multi-stage process, mediates the spread and growth of metastatic tumor at a new metastatic site from the primary tumor involving invasive cancer cells (Sahai, 2007) .
In several cases of human cancers, hypoxia-induced epithelial-mesenchymal transition (EMT) has been reported to be associated (Yeo et al., 2017) . In hypoxic tumor microenvironment, prolonged hypoxic exposure (oxygen de ciency) of tumor cells might cause a tumor to acquire more aggressive phenotypes (Yeo et al., 2017) .
Cancer stem cells (CSCs), generated in part as a consequence of epithelial-mesenchymal transition (EMT) are increased in case of hypoxia-induced EMT during tumor progression. Although, EMT causes the conversion of the epithelial cells into mesenchymal cells through loss of cell polarity, the recent observation implies the critical role of EMT in tumor progression and modulation of an early stage tumor into an invasive malignancy (Yeo et al., 2017) . is hypoxic microenvironment can also be generated by mitochondrial dysfunction where the mitochondrial metabolites accumulate in the cytoplasm due to the imbalance between glycolysis and oxidative phosphorylation (Roberts & Jean, 2013) .
Apoptosis or programmed cell death, a cellular defense mechanism, plays an important role in surveillance of tumors or other malfunctioning cells and it is also highly regulated and non-in ammatory (Steller, 1995) . Apoptosis signi cantly di ers from necrosis which is another form of cell death causing in ammation and group of cells death (Payne & Miles, 2008) . Apoptotic cells undergo several morphological and biochemical changes, such as chromatin condensation, nuclear segmentation, internucleosomal DNA fragmentation, cytoplasmic vacuolization, cell shrinkage and membrane blebbing with shedding of apoptotic bodies etc. (Häcker, 2000; Wyllie, 1992) . Any defect in apoptosis process rendering uncontrolled proliferation of cells could also lead to cancer (Amran, 2017) . Beyond self-defense mechanisms, carcinogenesis is prevented by several other modes e.g. the antioxidant e ects. Antioxidants such as superoxide dismutase, catalase, glutathione peroxidase, reductase and S-transferases scavenge the ROS before their access into the cell for the target molecules (Halliwell, Gutteridge, & Cross, 1992) .
Antioxidants like vitamins, α-and β-carotene, curcumin, lycopene, β-Cryptoxanthin, Esculetin, catechin etc., widely distributed in fruits and vegetables, play key roles in cancer inhibition by inducing oxidative stress in cancer cells. Likewise, fatty acids, amino acids and related compounds, avonoids, resveratrol, di erent alkaloids and phenolic compounds from natural sources impede carcinogenesis (Reddy, Odhav, & Bhoola, 2003) . e available cancer treatments such as surgery, radiation therapy, chemotherapy, immunotherapy, hormone therapy or combination of these therapies are long and expensive processes which require sophisticated infrastructure development and maintenance with skilled personnel. e success of a cancer therapy depends on its preferential wipeout of cancer cells with negligible toxicity to the normal cells (Amran, 2017) . Targeted therapy using monoclonal antibodies is, therefore, turning to be useful gradually (Adams & Weiner, 2005) . Chemotherapeutic drugs interfere in cancer cell proliferation by cell cycle-speci c or cell cycle-nonspeci c manner and most common constituents of this are alkylating agents, heavy metals, anti-metabolites, cytotoxic antibiotics, topoisomerase inhibitors to prevent DNA replication or protein synthesis and damage mostly S-phase of cell cycle (Payne & Miles, 2008) . Although conventional treatments consisting of surgical resection, radiotherapy and chemotherapy are e ective in managing many of the patients (generally prolonged life or permanent cure of cancer), almost 50% of the cases are unmanageable. Also the side e ects such as pain, blood clots, fatigue, anemia, thrombocytopenia, constipation, diarrhea, or neurological complications and unpleasant to fatal infections are very o en accompanied by these treatments (Aslam et al., 2014) .
Research for alternative therapies, aimed at minimizing the side e ects and increasing the survival rates, is a continuous process worldwide and in this connection, exploration for anti-cancer agents from numerous sources (e.g. microbes, plants and nanoparticles) are carried out routinely. Anticancer activities of several bacterial components were reported and a safe vaccine was developed by American physician William Coley a hundred years ago from killed bacterial species to treat sarcomas, carcinomas, lymphomas, and melanomas successfully (Hoption Cann, van Netten, & van Netten, 2003; Zacharski & Sukhatme, 2005) . A er several decades, a variety of natural and genetically modi ed non-pathogenic bacterial species were explored for their potency against tumor cells either for direct tumoricidal e ects or tumoricidal molecules (Patyar et al., 2010) .
Microorganisms produce over 50000 metabolites among which more than 40% were reported with biological activities. Microorganism derived anticancer agents are Actinomycin, Bleomycin, Daunomycin, Doxorubicin, Epirubicin, Idarubicin, Mitomycin C, Geldanamycin, Rapamicin and Wortamannin which are used clinically to treat di erent forms of cancer mainly by blocking signal transduction pathways (Bhanot, Sharma, & Noolvi, 2011) .
Bacteria produce over 3800 bioactive metabolites and of them, Bacillus spp. and Pseudomonas spp. are the most prominent sources, producing about 860 and 795 metabolites respectively (Bérdy, 2005) . Polyketides, macrolactones, fatty acids, lipoamides, isocoumarin, lipopeptides and polypeptides are most abundant bioactive compounds from terrestrial and marine Bacillus spp. (Hamdache, Lamarti, & Collado, 2011; Meena, Sharma, & Kanwar, 2017) which exhibit a wide range of biological activities, such as antibacterial, antifungal, anti-algal, antioxidant, antifouling and most importantly anticancer activity (Baruzzi, Quintieri, Morea, & Caputo, 2011; Hamdache et al., 2011) .
On the other hand, Bacillus spp. are the best characterized Gram-positive bacteria, being utilized industrially for long in producing microbial enzymes and therapeutically important chemicals, due to their feasibility in economic bioprocess (Liu et al., 2013; Papagianni, 2012) . Hence, Bacillus species could be the appropriate sources of numerous bioactive molecules in developing new drugs for cancer therapy. is review, therefore, focuses on di erent Bacillus species synthesizing metabolites with anticancer activity and reports certain previous clinical trials in assessing their e cacy to cure cancer.
Genus Bacillus
A key distinguishing feature of the family Bacillaceae is the production of endospores which are round, oval, or cylindrical highly refractile structures formed within bacterial cells. is characteristics attracted the early interest of microbiologists which has continued still (Slepecky & Hemphill, 2006) . Certain other special features of the genus Bacillus are their aerobic nature (strict or facultative), rod shape and catalase production.
Bacillus spp. are also renowned for producing antibiotics as secondary metabolites and ca. 169 of them were recorded so far.
As for instance, di erent strains of B. subtilis and B. brevis produced 68 and 23 antibiotics respectively (Debabov, 1982) .
Usually, Bacillus species were reported to produce at least one extracellular enzyme besides di erent carbohydrates such as di erent proteases, penicillinases, nucleases, phosphatases, lipase, phospholipase C, thiaminase, and bacteriolytic enzymes etc (Debabov, 1982) . Beside production of large quantities of enzymes for industrial purposes, various biologically active molecules were identi ed, isolated and checked for their activities from Bacillus spp. and these are summarized in the Table 1 and Table 3 .
Bacillus amyloliquefaciens
Bacillus amyloliquefaciens is an endophytic bacteria and this type of bacterium is one of the major sources of natural anticancer agents including anthracyclines, glycopeptides, aureolic acids, anthraquinones, enediynes, antimetabolites, carzinophilin and mitomycins (Blunt, Copp, Hu, Munro, & Northcote, 2008) .
Bacillus amyloliquefaciens MD-bl
Bacillus amyloliquefaciens MD-bl, isolated from the medicinal plant Ophiopogon japonicas was reported for its exopolysaccharides exhibiting dose-dependent inhibitory e ects against the gastric carcinoma cell lines, MC-4 and SGC-7901 cells, with an IC 50 of 19.7 and 26.8 µg/µl, respectively, as revealed in MTT assay (C. Li, 2013) . Polysaccharides are a group of water-soluble bioactive compounds associated with immune system modulation, including antitumoral, antiviral and antioxidant activities (Strobel et al., 2004) . Upon administration, cancer cells were found to be damaged or dead with evident morphological abnormalities and mitochondrial dysfunction, indicating the apoptosis inducing e ect by the polysaccharides. is was the rst discovery of such anticancer exopolysaccharides derived from the genus Bacillus (C. Li, 2013) .
Bacillus amyloliquefaciens AK-O
Bacillus amyloliquefaciens AK-0, a recently isolated bacterium from the rhizospheric soil of Korean ginseng, exerted anti-proliferative activity against human colorectal cancer cells such as HCT116, SW480, LoVo and HT-29 which e ectively decreased cyclin D1 protein level in human colorectal cancer cells .
Bacillus cereus
Bacillus cereus is a Gram-positive, rod shaped, aerobic to facultative, beta hemolytic and soil-dwelling bacterium, one of the causative agents of food poisoning, especially 'Fried rice syndrome' (Bottone, 2010) . Bacillus thuringiensis (Bt) is closely related to B. cereus but Bt produce unique proteinaceous crystalline proteins, only discriminatory fact between these two bacteria.
Many strains of Bc can function as probiotics providing health bene ts to the host when administered in adequate amounts (Araya et al., 2002) . Probiotic bacteria are known to produce bioactive substances that exhibit antibacterial, antiviral and anti-tumor properties (Austin, 1989) . Probiotic consumption helps the host to maintain intestinal microbial balance, reduce the number of pathogens, improve bowel regularity, restore normal intestinal microbiota and reduce the level of carcinogens (Reid, Jass, Sebulsky, & McCormick, 2003) .
Bacillus cereus (BC1)
Anticancer metabolites were obtained from an Indian Bacillus cereus strain a er successive solvent extraction with petroleum ether, ethyl acetate or methanol (1:1). One of fractions BC1
showed CTC 50 (cytotoxicity 50%) values of 225.4 µg/ ml against Hep-2 (human laryngeal epithelial carcinoma cell lines). From the mass spectroscopic analysis of TLC fractions of BC1, it was revealed that the fraction was devoid of any proteins .
Bacillus cereus SVSK2
Bacillus cereus SVSK2, a probiotic bacteria, isolated from 
Bacillus subtilis
Bacillus subtilis, an inhabitant of the upper layers of the soil, is a rod-shaped Gram-positive spore forming bacterium and capable of growing in minimal nutritional conditions (Piggot, 2009; van Dijl & Hecker, 2013) . In such conditions, B.
subtilis can undergo a series of responses including synthesis of antibiotics and extracellular enzymes, competence to take up DNA, motility and bio lm formation (Piggot, 2009 ). Many of the B. subtilis strains isolated from di erent regions with anticancer properties are discussed below.
Bacillus subtilis strain FS05
Crude extracts of Bacillus subtilis strain FS05, 
Bacillus subtilis SVSK5
Bacillus subtilis strain SVSK5 isolated from the gastro-intestinal tract of sh (Labeo rohita) was found to express Eicosane, Pentacosane, Phthalic acid etc. ese compounds altogether exhibited cytotoxicity against MCF-7 and HeLa cells at 150 µg/ ml and 300 µg/ ml respectively in MTT assay (Seerangaraja et al., 2017) .
Bacillus subtilis B1779
A red sea bacterium, B. subtilis strain B1779 (Meena et al., 2017) .
Bacillus licheniformis
Bacillus licheniformis, a mesophilic spore-former commonly found in soil and bird feathers (Veith et al., 2004) is part of the subtilis group along with Bacillus subtilis and Bacillus pumilus.
ough B. licheniformis possess similar (about 80%) coding sequence to B. subtilis, the amount and location of prophages, transposable elements, extracellular enzymes, and secondary metabolic pathway operons make it di erent from B. subtilis (Rey et al., 2004) . is bacterium is industrially important because of its ability to produce a range of extracellular enzymes, especially proteases. Due to their activity at high pH and thermostability, proteases from this bacteria became an useful ingredient in laundry detergent which prevents shrinkage and fading of colors (D. Kumar et al., 2008) . Apart from this, keratinase produced by B.
licheniformis is used in leather industry as dehairing agent as well as in feed industry for feather digestion (Hoq et al., 2005; Lin et al., 1992; Tiwary & Gupta, 2010) . Protease and keratinase were also expressed in heterologous expression system through recombinant DNA technology in several occasions for easy and feasible downstream processing (Jacobs, Eliasson, Uhlén, & Flock, 1985; Nahar et al., 2016; Radha & Gunasekaran, 2007; Sareen, Bornscheuer, & Mishra, 2005; Tang et al., 2004) . B. licheniformis produces bacitracin and also used as probiotic (Azarin, Aramli, Imanpour, & Rajabpour, 2014; Haavik, 1979) . 
Bacillus licheniformis sp. (Levan producing)

Bacillus licheniformis 09IDYM23:
Bacillus licheniformis strain 09IDYM23 was isolated from marine enzyme was reported to be free of any toxic e ect on human erythrocytes and CHO cell lines (Mahajan et al., 2014) .
Bacillus megaterium
Bacillus megaterium (Bm) is a Gram-positive spore forming bacterium and the key distinguishing feature of this bacterium from other Bacillus spp. is its immense size. is bacterium is the largest of all bacilli. Generally, most of the genome sequence of Bacillus spp. are closely related to B. cereus or B. subtilis but Bm is the only distantly related to B. cereus or B. subtilis (Eppinger et al., 2011; Porwal et al., 2009) . Bm is the one of the rst bacterial genome that has been fully coded and is frequently used as nonpathogenic host for the biotechnological production of a wide variety of substances like Vitamin B12, penicillin acylase, amylases and many more (Eppinger et al., 2011) . (Chatterjee et al., 2000) . Beside the anticancer activity of betulinic acid metabolites, betulinic acid has also anti-tumor activity against di erent type of cancer cells including human melanoma (Pisha et al., 1995) .
Bacillus flexus
Bacillus exus (SAmt74) produced a low molecular weight exopolysaccharide, EPS-7 (3.756× 104 g/ mol) which showed signi cant cytotoxicity (IC 50 -372 µg/ ml) against HepG2 cells having 24% sulfur content (Abdelnasser et al., 2017) .
Bacillus sp. BS3
A halophilic Bacillus sp. BS3, isolated from solar salt works, produced biosurfactants such as 3-Docosenamide, Mannosamine, 9-Octadecenamide, 2-Octanol, 2-methyl-6methylene, Cylohex-1, 4, 5-triol-3-one-1-carbo and 1, 2-Ethanediamine, N, N, N' , N'-tetramethyl-which showed varied cytotoxicities (maximum 24.8%) against mammary epithelial carcinoma cells (Donio et al., 2013) . Microorganism derived biosurfactants could be glycolipids, lipopeptides, lipopolysaccharides, polysaccharide-protein complexes, fatty acids and lipids (Makkar et al., 2011) with enormous applications in therapeutic and biomedical elds such as antibacterial, antifungal, antiviral, anticancer, immunomodulator, anti-adhesive, antioxidants, dermal broblasts stimulant, vaccines and gene therapy (Bhadoriya & Madoriya, 2013; Gudina et al., 2013) .
Bacillus safensis strain PDRV
Crude extracts of Bacillus safensis strain PDRV, isolated from Red sea sponge Amphimedon ochracea, showed cytotoxicity against three established human cancer cell lines; HepG2 (hepatocellular carcinoma), HCT (colon carcinoma) and MCF-7 (breast carcinoma) with IC 50 of 46.9, 28.6 and 21.3 µg/ml, respectively following MTT assay (Aboul-Ela et al., 2012) .
Bacillus thuringiensis
Bacillus thuringiensis (Bt) synthesizes δ-endotoxins (Cry, Cyt or parasporin proteins) in its parasporal body during sporulation which was reported for antitumor e ects and unique activity speci cally against cancer cells (Mizuki et al., 1999; Prasad & Shethna, 1974) besides long history and application as biopesticide for larvicidal activity. e toxicity of the parasporins were reported against various cancer cells such as MOLT-4, HeLa,
HepG2, JURKAT, HL60, TCS, CACO-2 etc ( Table 2) upon their proteolytic activation (Mizuki et al., 1999) with non-toxicity against normal cell lines (S. Okumura et al., 2010) . To date, 19
parasporins were discovered and categorized into 6 major classes (PS1-PS6) (S. Okumura et al., 2010) and few other parasporin like
proteins are yet to be classi ed (Poornima et al., 2010; Gonzalez et al., 2011; Ammons et al., 2016) . Among these six classes of parasporin, only PS1 kills cancer cells by activating apoptotic signaling pathway causing from attenuation of cellular protein and DNA synthesis, and by increasing in ux of calcium ions (Katayama et al.,2007) . It was reported that parasporin-1 could bind to the receptor Beclin 1 in the cell membrane (Katayama et al.,2007; Xu, Wang, & Yu, Ziniu and Sun, 2014) . In case of parasporin 2, it accumulates in lipid ra s on target cell surfaces through interaction with a putative proteinaceous receptor which gets associated with the glycan core of GPI-anchored proteins for stability. PS2
subsequently forms a membrane embedded oligomer that forms pore and induces permeability of the plasma membrane leading to cell death (Abe et al., 2017) . Other PS proteins also kill cells by pore formation.
Bacillus thuringiensis S13
Bacillus thuringiensis S13, found in the coastal soil samples, produced anti-proliferative exopolymer which inhibited lung cancer cell line (A549) with an IC 50 of 133.27 μg/ ml as detected using XTT assay. FTIR spectra of exopolymer revealed that a brominated compound 1,1,3,1"-Terphenyl,3,3,5,5-tetrabromo-5-(3,5-dibromophenyl) was present in the exopolymer that could be responsible for cytotoxicity (Parthiban et al., 2014) .
Bacillus mojavensis B0621A
Bacillus mojavensis B0621A, isolated from Pinctada martensii (Pearl Oyster) in the South China Sea, exerted three iturinic lipopeptides that were isolated by bioactivity-guided fractionation. ey were identi ed as Mojavensin A ( Supplementary Fig.   3 ), iso-C16 fengycin B and anteiso-C17 fengycin B and inhibited the growth of human leukemia cell line HL-60 with IC 50 of 100, 100 and 1.6mM, respectively as revealed in MTT assay (Z. Ma et al., 2012) .
Bacillus silvestris
Bacillus silvestris isolated from a Paci c Ocean (southern Chile) crab, produced bacillistatins 1 ( Supplementary Fig. 4) etc with GI 50 of 10−4-10−5 μg/ mL (Pettit et al., 2010) .
Bacillus vallismortis BIT-33
Bacillus vallismortis BIT-33 produced a secondary metabolite, PCC demonstrated anticancer cell activity with a concentration of 10 μg/ ml where cell viability was about 40% causing apoptosis of cells in a dose-and time-dependent manner (Jeong et al., 2008) .
Bacillus polyfermenticus
Bacillus polyfermenticusis a probiotic bacterium which was rst found in the air by Dr. Terakado (1933) and was used in the treatment of intestinal disorders (Lee, Park, Park, & Paik, 2007; L. Ma et al., 2010) . Probiotic bacteria exert anticancer properties through improvement of normal intestinal microbiota, immune modulation, degradation of potential mutagens and enhancement of local and systemic antioxidant activity (Reid et al., 2003; Yu & Li, 2016) .
Bacillus polyfermenticus SCD showed cytotoxicity against colon cancer cells, Caco-2 in a dose dependent manner. A er 72 hours of treatment, growth of Caco-2 cells was inhibited 24.6%, 20.3%, 37.1% and 42.2% with B. polyfermenticus SCD concentration at 100, 500, 1000 and 2000 μg/ml, respectively (Lee et al., 2007) . (Kumar et al., 2013) .
Marine Bacillus sp.
Bacillus sp., isolated from sea mud near the Arctic pole, produced three new cyclopeptides belonging to iturin class named as mixirins A, B and C. Mixirins A, B and C inhibited the growth of human colon cancer cells (HCT-116) with IC50 of 0.68, 1.6, 1.3 mg/ml, respectively (ZHang et al., 2004) . Lipopeptides like iturin was reported to be cytotoxic against di erent cancer cells ( Dey et al., 2016) . (Ekino et al., 2014; Ito et al., 2004; Katayama et al., 2005; Nagamatsu, Okamura, Saitou, Akao, & Mizuki, 2010; Shiro Okumura, Saitoh, Ishikawa, Inouye, & Mizuki, 2011; Yamashita et al., 2005) . (Malkov, Markelov, Polozov, & Sobchuk, 2005) .
Cell line
Bacillus thuringiensis
Parasporin-4 (PS4), an aerolysin-type β-pore-forming toxin from Bacillus thuringiensis strain A1470 produced upon proteolytic activation (Shiro Okumura et al., 2011) was examined in mice model if this promising anticancer protein could be used in cancer therapy (Shiro Okumura, Koga, Inouye, & Mizuki, 2014) .
In ICR mice (a strain of albino mice sent from the Institute of Cancer Research in the USA), the LD 50 value was determined as 160 μg/ kg with the reduction of potassium, ammonium, magnesium ion, creatinine and urea nitrogen in urine and increased creatinine and urea nitrogen in mice serum that impaired kidney function. Upon oral administration of Pro-PS4 (10 mg dry wt/200 μL D.W.) in C57BL/6J mice thrice in a week for 40 days, no serious health hazard was observed (Shiro Okumura et al., 2014) .
Bacillus polyfermenticus
Probiotic bacterium Bacillus polyfermenticus (B.P) produced strong cytotoxic e ect against various cancer cell lines including colon, breast, cervical and lung cancers. Anti-cancer e ect of B.P.
was reported as detected in vivo using the mouse xenogra model of human colon cancer which caused the reduction in tumor size and weight by suppressing cell proliferation and angiogenesis. It was suggested that in Bacillus polyfermenticus due to the reduction of ErbB2 and ErbB3 expression, the E2F-1 and cyclin D1 expression is down-regulated in tumor cells leading to the inhibition of tumor growth (Ma et al. 2015) .
Conclusion
If identi ed at early stage, cancer is more likely to respond to e ective treatments and can result in less morbidity and less expenses. Bacillus spp. produce two major lipopeptides i.e. surfactin and iturins besides other unique metabolites like mojavensin, bacillistatins, ε -poly-L-lysine, halobacillin, PCC and EPS etc.
which exhibited toxicity against cancer cells. Nevertheless, many of these bioactive agents were not examined in vivo, e.g. in rodents, which is a major shortcoming of these metabolites to be used in preliminary cancer therapy (Burger & Fiebig, 2004) .
Moreover, although the crude extracts or conditioned medium of some Bacillus sp. showed cytotoxicity to cancer cells, the speci c active compounds are still unidenti ed. Further investigation in search of those active metabolites as well as in vivo study would be helpful in developing new anticancer drug from Bacillus species for a sustainable and economic cancer treatment process. 
Mode of action References
Exopolysaccharide Cause morphological abnormalities and mitochondrial dysfunction in tumor cells leading to apoptosis Amicoumacin A Inhibit mRNA translation (Prokhorova et al., 2016) ε -Poly-L-lysine Cause morphological changes and growth inhibition (Arnold, Dagan, Gutheil, & Kaplan, 1979) 
Surfactin
Inhibit tumor growth, cell cycle arrest, apoptosis and metastasis arrest (Wu et al., 2017) Levan Increase oxidative stress and apoptosis (Queiroz et al., 2017) L-asparaginase Causes nutritional de ciencies and inhibit protein synthesis resulting in apoptosis (Shrivastava et al., 2016) Ieodoglucomide B Inhibit tumor cell growth (Tareq et al., 2013) Bacillistatins 1 and 2 Inhibit tumor cell growth (Pettit, Arce, Chapuis, & Macdonald, 2015) Mixirins A, B and C Inhibit tumor cell growth (Harris & Pierpoint, 2012) Parasporin 1 Activates apoptotic signaling pathway by binding with Beclin 1 receptor and increase Ca 2+ in ux (Katayama et al., 2007) Parasporin 2 Permeabilize plasma membrane through GPIanchored protein (Abe et al., 2017) Parasporin 3 Pore formation (Ito et al., 2004) Parasporin 4 Cholesterol independent pore formation (Yamashita et al., 2005) Parasporin 6 Swelling of cells and vacuoles formation 
